« Previous
Next »
Titles
- Part D plans generally include drugs commonly used by dual eligibles: 20191
- Post-acute care and beyond: responding to the growing need for chronic care1
- Potential changes to Medicaid long-term care spousal impoverishment rules: States' plans and implications for community integration1
- Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates1
- Preliminary analysis of legislation that would replace subsidies for health care with block grants1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid1
- Prices for and spending on specialty drugs in Medicare Part D and Medicaid: an in-depth analysis1
- Prior authorization requirements for proprotein convertase subtilisin/kexin type 9 inhibitors across US private and public payers1
- Projected financial losses experienced by community health centers under a scenario of major cuts in key sources of federal funding: 2018-20221
- Putting Medicaid in the larger budget context: an in-depth look at three states in FY 2017 and FY 20181